ZA962438B - Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same - Google Patents
Acetamide derivative process for preparing the same and a pharmaceutical composition containing the sameInfo
- Publication number
- ZA962438B ZA962438B ZA962438A ZA962438A ZA962438B ZA 962438 B ZA962438 B ZA 962438B ZA 962438 A ZA962438 A ZA 962438A ZA 962438 A ZA962438 A ZA 962438A ZA 962438 B ZA962438 B ZA 962438B
- Authority
- ZA
- South Africa
- Prior art keywords
- same
- preparing
- pharmaceutical composition
- composition containing
- acetamide derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11393795 | 1995-04-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA962438B true ZA962438B (en) | 1996-10-01 |
Family
ID=14624947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA962438A ZA962438B (en) | 1995-04-13 | 1996-03-27 | Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same |
Country Status (25)
Country | Link |
---|---|
US (1) | US5972946A (zh) |
EP (1) | EP0826673B1 (zh) |
KR (1) | KR100433589B1 (zh) |
CN (1) | CN1094929C (zh) |
AR (1) | AR002289A1 (zh) |
AT (1) | ATE228113T1 (zh) |
AU (1) | AU694647B2 (zh) |
BR (1) | BR9604894A (zh) |
CA (1) | CA2218033A1 (zh) |
CZ (1) | CZ289093B6 (zh) |
DE (1) | DE69624916T2 (zh) |
DK (1) | DK0826673T3 (zh) |
ES (1) | ES2187644T3 (zh) |
HU (1) | HUP9801688A3 (zh) |
IL (1) | IL117659A (zh) |
NO (1) | NO310619B1 (zh) |
NZ (1) | NZ304982A (zh) |
PL (1) | PL322819A1 (zh) |
PT (1) | PT826673E (zh) |
RO (1) | RO117532B1 (zh) |
RU (1) | RU2160256C2 (zh) |
SK (1) | SK281840B6 (zh) |
TW (1) | TW450963B (zh) |
WO (1) | WO1996032383A1 (zh) |
ZA (1) | ZA962438B (zh) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0781766B1 (en) * | 1994-09-09 | 2004-03-31 | Nippon Shinyaku Company, Limited | Heterocyclic derivative and medicine |
CA2299710C (en) * | 1997-08-04 | 2007-11-27 | Taisho Pharmaceutical Co., Ltd. | Aryloxyaniline derivatives |
MXPA00004919A (es) * | 1997-11-21 | 2002-10-17 | Euro Celtique Sa | 2-aminoacetamidas sustituidas y uso de las mismas. |
ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
FR2778564B1 (fr) * | 1998-05-13 | 2001-07-13 | Sanofi Sa | Utilisation de composes reduisant l'apoptose |
WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
JP2002241369A (ja) * | 1998-05-18 | 2002-08-28 | Dainippon Pharmaceut Co Ltd | 4−ピリミジニルアミノアセトアミド誘導体及びそれを含有する医薬組成物 |
DE19853278A1 (de) | 1998-11-19 | 2000-05-25 | Aventis Pharma Gmbh | Substituierte 4-Amino-2-aryl-cyclopenta[d]pyrimidine, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US6380183B1 (en) | 1998-12-18 | 2002-04-30 | Scios, Inc. | Treatment of diseases involving cyst formation |
DE69932449T2 (de) | 1998-12-18 | 2007-03-15 | Scios Inc., Fremont | Agonisten und antagonisten von benzodiazepinrezeptoren des peripheren typs |
EP1607744A3 (en) * | 1998-12-18 | 2009-09-30 | Scios Inc. | Treatment of diseases involving cyst formation with combinations comprising a PTBR agonist |
WO2000043354A2 (en) | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
PL350050A1 (en) * | 1999-01-22 | 2002-10-21 | Elan Pharm Inc | Acyl derivatives which treat vla-4 related disorders |
AR035476A1 (es) | 1999-01-22 | 2004-06-02 | Elan Pharm Inc | Compuestos heteroarilo y heterociclicos con anillo fusionado, los cuales inhiben la adhesion de leucocitos mediada por vla-4, composiciones farmaceuticas, el uso de las mismas para la manufactura de un medicamento y un metodo para fijar vla-4 en una muestra biologica |
US6436904B1 (en) * | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
DE19904710A1 (de) * | 1999-02-05 | 2000-08-10 | Aventis Pharma Gmbh | Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
ATE264298T1 (de) | 1999-03-01 | 2004-04-15 | Elan Pharm Inc | Alpha-aminoessigsäure derivate als alpha 4 beta 7-rezeptor antagonisten |
US7037916B2 (en) | 1999-07-15 | 2006-05-02 | Pharmacopeia Drug Discovery, Inc. | Pyrimidine derivatives as IL-8 receptor antagonists |
NZ518702A (en) * | 1999-11-17 | 2004-04-30 | Dainippon Pharmaceutical Co | [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide derivatives, process for producing the same, medicinal compositions containing the same and intermediate of these compounds |
CA2373411A1 (en) * | 2000-03-16 | 2001-09-20 | Taeyoung Yoon | 5-substituted arylpyrimidines |
EP1301490A2 (en) * | 2000-07-18 | 2003-04-16 | Neurogen Corporation | 5-substituted 2-aryl-4-pyrimidinones |
US7473691B2 (en) * | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
EP1698627A1 (en) * | 2000-09-15 | 2006-09-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
CA2422354C (en) | 2000-09-15 | 2009-12-08 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
CN1926132B (zh) * | 2000-09-15 | 2010-12-29 | 沃泰克斯药物股份有限公司 | 可用作蛋白激酶抑制剂的吡唑化合物 |
US6660731B2 (en) * | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
JP2004518743A (ja) * | 2000-12-21 | 2004-06-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼインヒビターとして有用なピラゾール化合物 |
CA2469316A1 (en) * | 2001-12-07 | 2003-06-19 | Vertex Pharmaceuticals, Inc. | Pyrimidine-based compounds useful as gsk-3 inhibitors |
KR20040084896A (ko) * | 2002-02-06 | 2004-10-06 | 버텍스 파마슈티칼스 인코포레이티드 | Gsk-3의 억제제로서 유용한 헤테로아릴 화합물 |
US7015229B2 (en) | 2002-02-22 | 2006-03-21 | Pfizer Inc | Substituted pyrimidinones and pyrimidinthiones |
EP1485380B1 (en) * | 2002-03-15 | 2010-05-19 | Vertex Pharmaceuticals Incorporated | Azolylaminoazines as inhibitors of protein kinases |
TW200307671A (en) * | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
TWI281470B (en) * | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
MY141867A (en) * | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
CN101037438A (zh) | 2002-08-02 | 2007-09-19 | 沃泰克斯药物股份有限公司 | 用作gsk-3的抑制剂的吡唑组合物 |
CA2512899A1 (en) | 2003-01-14 | 2004-08-05 | Arena Pharmaceuticals Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
WO2004072029A2 (en) * | 2003-02-06 | 2004-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridazines useful as inhibitors of protein kinases |
AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
CN1894222A (zh) * | 2003-08-05 | 2007-01-10 | 沃泰克斯药物股份有限公司 | 作为电压门控离子通道抑制剂的稠合嘧啶化合物 |
US7378409B2 (en) * | 2003-08-21 | 2008-05-27 | Bristol-Myers Squibb Company | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
AU2004297235A1 (en) * | 2003-12-04 | 2005-06-23 | Vertex Pharmaceuticals Incorporated | Quinoxalines useful as inhibitors of protein kinases |
CA2554774A1 (en) * | 2004-02-23 | 2005-09-01 | Dainippon Sumitomo Pharma Co., Ltd. | Novel heterocyclic compound |
GT200600005A (es) * | 2005-01-12 | 2006-08-16 | Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene | |
WO2007022384A2 (en) * | 2005-08-18 | 2007-02-22 | Vertex Pharmaceuticals Incorporated | Pyrazine kinase inhibitors |
AU2006297180A1 (en) | 2005-09-29 | 2007-04-12 | Elan Pharmaceuticals, Inc. | Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
ATE493405T1 (de) * | 2005-09-29 | 2011-01-15 | Elan Pharm Inc | Pyrimidinylamidverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren |
EP1954277B1 (en) * | 2005-11-03 | 2017-01-18 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
KR20080067697A (ko) * | 2005-11-11 | 2008-07-21 | 에프. 호프만-라 로슈 아게 | 응고 인자 xa의 억제제로서 카보사이클릭 융합된사이클릭 아민 |
KR20080100271A (ko) | 2006-02-27 | 2008-11-14 | 엘란 파마슈티칼스, 인크. | Vla-4에 의해 매개되는 백혈구 부착을 억제하는 피리미디닐 술폰아미드 화합물 |
SI2001849T1 (sl) * | 2006-03-29 | 2015-02-27 | F. Hoffmann-La Roche Ag | Derivati piridina in pirimidina kot antagonisti mglur2 |
NZ576750A (en) * | 2006-11-02 | 2012-01-12 | Vertex Pharma | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
EP2099787B1 (en) * | 2006-12-19 | 2010-07-21 | Vertex Pharmaceuticals, Inc. | Aminopyrimidines useful as inhibitors of protein kinases |
EP1941879A1 (en) * | 2007-01-05 | 2008-07-09 | PAION Deutschland GmbH | Neuroprotective agent for the treatment of neuronal damage |
JP2010520887A (ja) * | 2007-03-09 | 2010-06-17 | バーテックス ファーマシューティカルズ インコーポレイテッド | 蛋白キナーゼの阻害剤として有用なアミノピリジン |
KR20090120510A (ko) * | 2007-03-09 | 2009-11-24 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제 억제제로서 유용한 아미노피리미딘 |
WO2008112642A1 (en) * | 2007-03-09 | 2008-09-18 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
WO2008116139A2 (en) * | 2007-03-22 | 2008-09-25 | Vertex Pharmaceuticals Incorporated | N-heterocyclic compounds useful as inhibitors of janus kinases |
NZ580343A (en) | 2007-04-13 | 2012-03-30 | Vertex Pharma | Aminopyrimidines useful as kinase inhibitors |
EP2152696B1 (en) * | 2007-05-02 | 2014-09-24 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
CA2685876A1 (en) * | 2007-05-02 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
MX2009011811A (es) * | 2007-05-02 | 2010-01-14 | Vertex Pharma | Aminopirimidinas utiles como inhibidores de cinasa. |
EP2164842A2 (en) * | 2007-05-24 | 2010-03-24 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
AR067762A1 (es) * | 2007-07-31 | 2009-10-21 | Vertex Pharma | Proceso para preparar 5-fluoro-1h-pirazolo (3,4-b) piridin-3-amina y derivados de la misma |
TWI378096B (en) | 2008-06-19 | 2012-12-01 | Takeda Pharmaceutical | Heterocyclic compound and use thereof |
RU2011112802A (ru) * | 2008-09-03 | 2012-10-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Сокристаллы и содержащие их фармацевтические композиции |
US8691866B2 (en) | 2008-12-10 | 2014-04-08 | The General Hospital Corporation | HIF inhibitors and use thereof |
SG10201401836RA (en) * | 2009-04-27 | 2014-10-30 | Elan Pharm Inc | Pyridinone antagonists of alpha-4 integrins |
GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
JP2013032290A (ja) * | 2009-11-20 | 2013-02-14 | Dainippon Sumitomo Pharma Co Ltd | 新規縮合ピリミジン誘導体 |
EP2619198A1 (en) | 2010-09-22 | 2013-07-31 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US9132129B2 (en) | 2010-11-15 | 2015-09-15 | Katholieke Universiteit Leuven | Antiviral compounds |
MX2021011472A (es) | 2015-01-06 | 2022-08-17 | Arena Pharm Inc | Metodos de condiciones de tratamiento relacionadas con el receptor s1p1. |
SI3310760T1 (sl) | 2015-06-22 | 2023-02-28 | Arena Pharmaceuticals, Inc. | Kristalinična L-argininska sol (R)-2-(7-(4-ciklopentil-3-(trifluorometil)benziloksi)-1,2,3,4- tetrahidrociklo-penta(b)indol-3-il)ocetne kisline za uporabo pri motnjah, povezanih z receptorjem S1P1 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3631036A (en) * | 1969-11-04 | 1971-12-28 | American Home Prod | 5-amino-2 6-substituted-7h-pyrrolo(2 3-d) pyrimidines and related compounds |
US3631045A (en) * | 1969-11-04 | 1971-12-28 | American Home Prod | 4 5-diamino-7h-pyrrolo(2 3-d)pyrimidine derivatives |
FR2263750A1 (en) * | 1974-03-12 | 1975-10-10 | Delalande Sa | N-phenyl-N-(2-aryl-6-methyl-pyrimidin-4-yl)amino acid derivs. - useful e.g. as analeptics, hypotensives, analgesics, etc. |
FR2525595A1 (fr) * | 1982-04-27 | 1983-10-28 | Pharmuka Lab | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
FR2582514B1 (fr) * | 1985-05-30 | 1988-02-19 | Rhone Poulenc Sante | Medicaments a base d'amides, nouveaux amides et leur preparation |
DK273689A (da) * | 1988-06-06 | 1989-12-07 | Sanofi Sa | 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler |
JPH07165721A (ja) * | 1993-12-15 | 1995-06-27 | Sumitomo Chem Co Ltd | 放射性イソキノリンカルボキサミド誘導体 |
-
1996
- 1996-03-26 IL IL11765996A patent/IL117659A/xx not_active IP Right Cessation
- 1996-03-27 ZA ZA962438A patent/ZA962438B/xx unknown
- 1996-04-10 CN CN96194408A patent/CN1094929C/zh not_active Expired - Fee Related
- 1996-04-10 NZ NZ304982A patent/NZ304982A/xx unknown
- 1996-04-10 BR BR9604894A patent/BR9604894A/pt not_active Application Discontinuation
- 1996-04-10 WO PCT/JP1996/000977 patent/WO1996032383A1/ja active IP Right Grant
- 1996-04-10 EP EP96909327A patent/EP0826673B1/en not_active Expired - Lifetime
- 1996-04-10 HU HU9801688A patent/HUP9801688A3/hu unknown
- 1996-04-10 CZ CZ19973223A patent/CZ289093B6/cs not_active IP Right Cessation
- 1996-04-10 SK SK1374-97A patent/SK281840B6/sk unknown
- 1996-04-10 US US08/930,604 patent/US5972946A/en not_active Expired - Fee Related
- 1996-04-10 AU AU52874/96A patent/AU694647B2/en not_active Ceased
- 1996-04-10 RU RU97118591/04A patent/RU2160256C2/ru active
- 1996-04-10 DE DE69624916T patent/DE69624916T2/de not_active Expired - Fee Related
- 1996-04-10 KR KR1019970707215A patent/KR100433589B1/ko not_active IP Right Cessation
- 1996-04-10 AT AT96909327T patent/ATE228113T1/de not_active IP Right Cessation
- 1996-04-10 ES ES96909327T patent/ES2187644T3/es not_active Expired - Lifetime
- 1996-04-10 PL PL96322819A patent/PL322819A1/xx unknown
- 1996-04-10 DK DK96909327T patent/DK0826673T3/da active
- 1996-04-10 PT PT96909327T patent/PT826673E/pt unknown
- 1996-04-10 CA CA002218033A patent/CA2218033A1/en not_active Abandoned
- 1996-04-10 RO RO97-01858A patent/RO117532B1/ro unknown
- 1996-04-12 AR ARP960102179A patent/AR002289A1/es not_active Application Discontinuation
- 1996-04-12 TW TW085104372A patent/TW450963B/zh not_active IP Right Cessation
-
1997
- 1997-10-10 NO NO19974685A patent/NO310619B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL117659A0 (en) | Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same | |
US5756817C1 (en) | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same | |
IL116673A0 (en) | A pharmaceutical composition containing a benzimidazole derivative and processes for the preparation thereof | |
IL114448A (en) | Beads for controlled release process for their preparation and a pharmaceutical preparation containing the same | |
IL128514A (en) | Acetamide derivatives, pharmaceutical compositions comprising them and a process for producing such derivatives | |
HU9603484D0 (en) | Pharmaceutical compositions and process for producing symptom-transduction | |
HUP9802694A3 (en) | Benzamide derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9603112A2 (en) | New pharmaceutical formulation and process for its production | |
HUP9802565A3 (en) | N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same | |
IL131298A0 (en) | A pharmaceutical composition and a process for producing the same | |
HUP9900055A3 (en) | 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridin -derivatives, process for producing them and pharmaceutical compositions containing them | |
IL122815A0 (en) | Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds | |
IL117629A0 (en) | Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof | |
HUP9600173A3 (en) | 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them | |
HUP9900079A3 (en) | 12h-dibenzo[d,g][1,3]dioxocine derivatives, process for their preparation, their use and pharmaceutical compositions containing the same | |
SG44059A1 (en) | Process for preparing acetoxyazetidinone derivative and intermediate thereof | |
ZA9610002B (en) | New compounds pharmaceutical preparations containing them and a process for the preparation thereof | |
GB2282966B (en) | A pharmaceutical composition having anti-decrepit action and a process for preparation thereof | |
HUP9600061A2 (en) | 3-alkoxycarbonyl-1,3,4-thiadiazin-2-on derivatives, process for their preparation and pharmaceutical compositions containing the same | |
ZA965023B (en) | N-substituted cis-n-propenyl-acetamides and process for their preparation | |
GB2302691B (en) | Oxaindene derivatives and process for the preparation thereof | |
GR3036226T3 (en) | 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same | |
HUP9600218A2 (en) | Substituted thiophenyl-sulfonyl-urea- and -thiourea derivatives process for producing them and pharmaceutical compositions containing them | |
EP0738707A3 (en) | Dianilinoglutacondialdehyde compounds and process for their preparation | |
HU9500156D0 (en) | Pharmaceutical composition and process |